title: Signaling molecule c-Met is a biomarker for favorable prognostic in Hodgkin lymphoma.
authors.affiliation: "Victor Babes" National Institute of Pathology, Bucharest, Romania. neagu.monica@gmail.com
authors.forename: Monica
authors.initials: M
authors.lastname: Neagu
authors.forename: Radu
authors.initials: R
authors.lastname: Albulescu
authors.forename: Cristiana
authors.initials: C
authors.lastname: Tanase